Canton Strategic Holdings (CNTN) Long-Term Debt Issuances (2021 - 2022)
Canton Strategic Holdings posted quarterly Long-Term Debt Issuances of $125000.0 for Q1 2022, down 61.3% year-on-year from $323025.0 in Q1 2021, and up 212.49% on a QoQ basis from $40001.0 in Q4 2021.
Canton Strategic Holdings (CNTN) has 2 years of Long-Term Debt Issuances data on file, last reported at $125000.0 in Q1 2022.
- For the quarter ending Q1 2022, Long-Term Debt Issuances fell 61.3% year-over-year to $125000.0; the trailing twelve-month figure through Dec 2022 stood at $125000.0 (down 88.4% YoY), and the FY2022 full-year result was $125000.0, down 88.4% from the prior year.
- Long-Term Debt Issuances for Q1 2022 stood at $125000.0, up from $40001.0 in the prior quarter.
- Across five years, Long-Term Debt Issuances topped out at $379989.0 in Q2 2021 and bottomed at $40001.0 in Q4 2021.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Issuances (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 2.73 Mn |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | - |
| 10 | Canton Strategic Holdings | 643.89 Mn | 602.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 125,000.00 |
| Mar 31, 2022 | 125,000.00 |
| Dec 31, 2021 | 40,001.00 |
| Dec 31, 2021 | 40,001.00 |
| Sep 30, 2021 | 335,000.00 |
| Sep 30, 2021 | 335,000.00 |
| Jun 30, 2021 | 379,989.00 |
| Jun 30, 2021 | 379,989.00 |
| Mar 31, 2021 | 323,025.00 |
| Mar 31, 2021 | 323,025.00 |